Minerva Neurosciences Inc (NERV) Annual Balance Sheets

Annual · GAAP · USD millions
Access NERV quarterly Balance Sheets →
Quarterly balance sheet trends provide context on Minerva Neurosciences Inc's liquidity, leverage, and long-term financial structure.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent82.30
Cash & Short-term Investments82.00
Other Current Assets0.10
Prepaid Expense, Current AS0.70
Total Current Assets83.10
Equipment/Property/Plant Net0.00
Goodwill net14.87
Other Assets, Noncurrent0.00
Restricted Cash Current0.10
Total Assets97.97
Liabilities
Accounts Payable, Current AC0.64
Other Liabilities, Current1.65
Total Current Liabilities2.29
Total Long-term Debt0.00
Other liabilities, Noncurrent231.46
LiabilityRelatedToSaleOfFutureRoyalties60.00
Total Liabilities233.76
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock548.05
Retained Earnings / Accumulated Deficit-688.80
Other Equity-4.96
Common Stockholder's Equity-145.71
Non-controlling interests & other4.96
Total Stockholder's Equity-140.75
Liabilities & Stockholder's Equity97.97
4 historic quarters locked

Sign in to unlock the full Minerva Neurosciences Inc balance sheet history.

About Minerva Neurosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-101117

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License